October 6, 2016 / 3:58 PM / in a year

BUZZ-Aurinia Pharmaceuticals Inc: Hits 5-year high on positive data

** Canadian drug developer’s U.S.-listed shares up as much as 40.5 pct at $5.69; highest in more than 5 years

** Reports positive data from open-label study for its drug to treat a type of lupus

** Lupus is a condition where the body’s immune system targets its own tissues

** The drug, voclosporin, is being developed to treat lupus nephritis, in which lupus targets the kidney, causing inflammation

** 7 out of 10 patients showed complete reduction in disease symptoms at week 24 of study when treated with the drug in combination with other treatments

** More than 22.5 mln shares traded, 9.4x 30-day moving avg

** Up to Wednesday’s close, stock gained more than 60 pct YTD

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below